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The manufacture of complex therapeutic proteins using mammalian cells is well estab-
lished, with several strategies developed to improve productivity. The application of sus-
tained mild hypothermic conditions during culture has been associated with increases in
product titer and improved product quality. However, despite associated cell physiological
effects, very few studies have investigated the impact on downstream processing (DSP).
Characterization of cells grown under mild hypothermic conditions demonstrated that the
stationary phase was prolonged by delaying the onset of apoptosis. This enabled cells to
maintain viability for extended periods and increase volumetric productivity from 0.74 to
1.02 g L21. However, host cell proteins, measured by ELISA, increased by 50%, attributed
to the extended time course and higher peak and harvest cell densities. The individual com-
ponents making up this impurity, as determined by SELDI-TOF MS and 2D-PAGE, were
shown to be largely comparable. Under mild hypothermic conditions, cells were less shear
sensitive than those maintained at 37C, enhancing the preliminary primary recovery step.
Adaptive changes in membrane fluidity were further investigated by adopting a pronounced
temperature shift immediately prior to primary recovery and the improvement observed sug-
gests that such a strategy may be implementable when shear sensitivity is of concern. Early
and late apoptotic cells were particularly susceptible to shear, at either temperature, even
under the lowest shear rate investigated. These findings demonstrate the importance of con-
sidering the impact of cell culture strategies and cell physiology on DSP, by implementing a
range of experimental methods for process characterization. VC 2013 American Institute of
Chemical Engineers Biotechnol. Prog., 000:000–000, 2013
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Introduction
The demand for therapeutic proteins produced by mamma-
lian cell lines, such as Chinese hamster ovary (CHO) cells,
continues to grow. Significant achievements in process opti-
mization have been made to meet the clinical demands of
these proteins, which can have very high dosing regimes, of-
ten of more than 1 g per dose.1 These include incorporation
of enhanced cell line selection technologies, development of
media and feeds, and scale-up to bioreactor volumes of up to
25,000 L.2 Despite these improvements additional strategies
have been adopted to increase volumetric productivities,
extending the use of existing manufacturing facilities and
reducing the capital expenditure associated with building and
validating new facilities or outsourcing to contract manufac-
turer organizations. These have included the optimization of
dissolved oxygen tension (DOT), pH, and temperature, all of
which have been shown to have an influence cell metabo-
lism, productivity, and product quality.3–5 The use of mild
hypothermic conditions, by lowering the culture temperature
to below the normal physiological temperature of 37C, to
enhance cell specific productivity of recombinant proteins,
has been extensively studied.5–8 It should also be considered
that dissolved oxygen concentration increases as temperature
is reduced.3,9 However, the effect of decreasing the culture
temperature on downstream processing (DSP) performance
and host cell protein (HCP) profile has yet to be considered.
Lowering culture temperature is a strategy used to control
cell proliferation during cell culture and is typically
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employed during the mid or late exponential growth
phases.10 Reducing the culture temperature arrests cells in
the G1-phase of the cell cycle when the cells are larger11
and have a lower glucose consumption and oxygen uptake
and lactate and ammonia production than nonarrested
cells.9,10 Mild hypothermic conditions also have the advant-
age of extending the stationary phase and maintaining higher
cell viability,8 improved product quality3,12 and decreasing
the sensitivity to apoptotic agents.13
It has been reported that the effect of lowering culture
temperature on cell specific productivity is cell line depend-
ent.14 In some cases increases in cell specific productivity5–7
have been observed whilst in others the productivity
decreases or remains comparable to nonarrested cells.9,14
The glycosylation profile of recombinant proteins can be
affected by the culture conditions, such as pH, temperature,
culture media and mode of operation.15,16 It has been sug-
gested that reducing culture temperature helps to retain the
glycoform, as high cell viability is maintained throughout
culture and the release of glycosidases, which target mono-
saccharides from the glycan, is minimized.7,15
Although a number of studies have been undertaken on
mild hypothermic conditions, these have largely focussed on
understanding the physiological response to this stress and
on the identification of key biomarkers associated with it. In
line with the quality by design (QbD) measures being
adopted industry-wide further understanding of the effects of
implementing strategies such as mild hypothermic conditions
at process scale, on both the manufacturing process and the
target product itself is becoming increasingly important to
regulators.17 To assist with such activities, the availability of
scale-down methodologies which accurately mimic process
scale operations for process development and validation pur-
poses has become paramount. Until recently much of this
work has focussed on cell culture, including high throughput
screens in microwell plates and miniature bioreactor for-
mats18 or on purification process steps in geometrically scal-
able chromatography columns or other alternative scale-
down formats.1 As these tools continue to evolve, integration
of primary recovery is being seen as increasingly important
in the development process, to understand its impact on the
release of process related impurities. This is being achieved
by the development of a number of scale-down methodolo-
gies for these process operations, including for centrifuga-
tion,19,20 microfiltration,21 and depth filtration.22
In this study, we examine the effect of mild hypothermic
conditions on an industrially relevant IgG4 producing GS-
CHO cell line grown in monitored and controlled stirred
tank bioreactors (STRs), operated under fed-batch mode with
serum free media. Using flow cytometry-based assays, we
investigate the physiological effects of mild hypothermic
conditions on the cells at certain time-points during fermen-
tation. We have previously demonstrated that cell physiology
can play an important role in primary recovery performance,
particularly during operations such as centrifugation, which
is associated with the high levels of energy dissipation that
can cause cellular damage during processing.23,24 We have
therefore considered the potential impact of these cellular
responses on the DSP. First, we evaluate differences in the
impurity profile challenging the purification process by using
a variety of analytical techniques. We then examine the
impact on centrifugation performance by using an ultra
scale-down (USD) methodology.
Material and Methods
Cell culture
Experiments were carried out using a Glutamine synthe-
tase Chinese hamster ovary (GS-CHO) cell line stably
expressing an IgG4 monoclonal antibody (CY01 cell line,
generously provided by Lonza Biologics, Slough, UK), as
described in Velez-Suberbie et al.25 Two bioreactors were
run in parallel with working volumes of 3.5 L and set points
of pH 7.1 and DOT 30% of air and were inoculated simulta-
neously using the same seed culture. Both bioreactors were
operated at 37C until late exponential phase (day 6) when
the temperature was shifted to 32C in one bioreactor and
maintained for the duration of the culture.
For investigating reduced processing temperature, samples
were taken from a fed-batch bioreactor run, which was per-
formed as described above, under standard conditions. Sam-
ples were taken at high and low viabilities and either
immediately used at culture temperature for USD shear and
centrifugation or adjusted to 4C and held for 5 h, prior to
processing.
USD shear and centrifugation studies
A rotating shear device, mimicking the shear typically
experienced in the feed zones of industrial centrifuges and a
96-well plate bench-top centrifugation method, providing a
range of clarification conditions representing a range of volu-
metric flow rates at process-scale were used as described
previously.23
Analytical Techniques
N-glycan release, labeling, clean-up, and analysis
Supernatant from samples was taken on days 10 and 12
(37C) and 14 and 20 (32C) and purified and prepared for
mass spectrometry analysis as described previously in Velez-
Suberbie et al.25
Apoptosis staining
Progression into apoptosis was determined from day 8
onwards by staining with a commercially available annexin
V-FITC/7ADD kit (Invitrogen, Paisley, UK) and analysis
using a Coulter Epics XL-MCL Flow Cytometer (Beckman
Coulter, High Wycombe, UK). Cell culture samples were
prepared following Manufacture’s protocol, analyzed using
488 nm excitation and detected using 525 and 675 nm band-
pass filters for annexin V and 7-ADD, respectively, and col-
lected for 300 s or 10,000 events. All samples were analyzed
within 30 min of staining. Positive control samples were an-
alyzed to ensure appropriate gating was applied.
Cell cycle analysis
Cell cycle distribution was determined from day 8
onwards using propidium iodide staining combined with
flow cytometry (Coulter Epics XL-MCL, Beckman Coulter).
Cell culture samples were centrifuged (Eppendorf 5415,
Cambridge, UK) at 500g for 5 min at 20C, the supernatant
discarded and the cell pellet washed in PBS. The suspension
was centrifuged again at 500g for 5 min at 20C, the super-
natant was discarded and the cell pellet resuspended in 70%
ice cold ethanol to a concentration of 5 3 106 cells mL21.
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Cells were fixed for 30 min at 4C, and then centrifuged at
1500g for 5 min at 20C. The supernatant was discarded and
the pellet was resuspended in 0.5 mL of PBS. The cell sus-
pension was centrifuged at 800g for 5 min at 20C, the su-
pernatant discarded, 75 mL of a 100 mL mL21 of
Ribonuclease A solution (Sigma-Aldrich, Gillingham, UK)
was added and incubated for 5 min at room temperature.
Propidium iodide (0.75 mL of a 50 mL mL21 solution) was
added and incubated for 5 min at room temperature (Sigma-
Aldrich). The samples were analyzed by flow cytometry
(Coulter Epics XL-MCL, Beckman Coulter) using 488 nm
excitation and a 675 nm band-pass filter for detection. To
obtain the cell cycle distribution, the histogram data file gen-
erated was analyzed using the Cylchred program (Cardiff
University, Cardiff, UK).
Particle size distribution analysis
A CASY analyzer (Innovatis, Bielefeld, Germany) was
used to determine the particle size. The CASY was used
with a 150 mm orifice and set to measure up to 40 mm with
a 5 times repeat measurement, from which an average was
reported. The particle volume was calculated from the diam-
eter determined, assuming all particles were spherical. The
volume was then determined as a percentage of the entire
volume of material present.
Product concentration by HPLC analysis
The mAb concentration was determined by protein G-HPLC
analysis using an Agilent 1200 HPLC (Agilent Technologies,
South Queensferry, UK). Samples (100 mL) were loaded onto
a 1 mL HiTrap protein G column (GE Healthcare, Pittsburgh,
PA), washed with 20 mM sodium phosphate, pH 7.0 and
eluted using 20 mM glycine hydrochloride, pH 2.8, with ab-
sorbance measured at 280 nm. The product peak was inte-
grated and the concentration determined using a standard
curve of purified mAb of known concentration.
HCP ELISA
HCP concentration was determined using a commercially
available microtiter sandwich ELISA (Cygnus Technologies,
NC), as described previously.26
Surface-enhanced laser desorption ionization: time of flight
(SELDI-TOF) mass spectrometry
Samples were prepared and analyzed as previously
described,26 using normal phase SELDI chips (NP20, Bio-
Rad Laboratories, Hemel Hempstead, UK).
2D-Polyacrylamide Gel Electrophoresis (2D-PAGE)
Samples from the relevant timepoints of each culture were
prepared and Isoelectric focussing and SDS-PAGE per-
formed as previously described.26 The gels were then stained
with Sypro Ruby (Invitrogen), according to the manufac-
turer’s protocol and scanned using a Typhoon 9400 laser
scanner (GE Healthcare), with the following settings; 600 V
PMT, 532 nm (green laser) for excitation and 610BP30
emission filter and a pixel size of 100 mm.
Progenesis Samespots software was used for spot compari-
son (version 4.0, Nonlinear Dynamics, Newcastle upon
Tyne, UK). After selecting an appropriate reference image
the gels were aligned by adding manual vectors and then fur-
ther aligned with additional automatic vectors. All images
were selected for further processing and all detected spots
subsequently normalized. Gel images were then divided into
the two experimental groups and compared using the
between-subject-design analysis function. Detected spots
were reviewed on a one to one basis and adjusted where
appropriate (e.g., splitting and merging of spots). Compari-
son between the two groups was made, using the software to
perform an ANNOVA test and generate P values, power val-
ues and fold change differences of selected spots. Only spots
with P values of <0.05 and power values of >0.8 were
selected. Any spots identified in areas of the gels masked by
mAb heavy or light chains in any of the samples analyzed
were discounted.
Results and Discussion
In the following sections, we discuss the implications of
implementing mild hypothermic conditions, a commonly
used cell culture strategy to improve product titer, on the
subsequent stages within DSP. We first examine the change
in physiology that occurs to CHO cells grown under mild
hypothermic conditions (32C) and then go on to investigate
how the change in culture conditions can also affect the im-
purity profile of the process stream, specifically the HCP
population. Finally, we evaluate how the physiological
changes associated with mild hypothermic conditions can
affect the shear susceptibility of cells and as a consequence
the performance of process-scale centrifugation, which is
commonly used for primary recovery in large-scale biophar-
maceutical manufacture.
The physiological response of GS-CHO cells to mild
hypothermic conditions
To investigate the effect of mild hypothermic conditions
(32C) on mammalian cells grown in suspension, two 5 L
fed-batch cultures were grown in parallel using a model
mAb producing GS-CHO cell line. Operating conditions
were matched in each bioreactor until a cell density of 8 3
106 cells mL21 was obtained (day 6), indicating an end to
the exponential phase, at which point the temperature of one
reactor was shifted from 37C to 32C until harvest. As has
been demonstrated previously,5–8,27 the application of mild
hypothermic conditions prolonged the stationary phase com-
pared with the culture maintained at 37C (Figure 1), and
cell viability was maintained above 80% until day 20 of cul-
ture, whereas viability dropped to below 80% on day 12 under
standard culture conditions. Further analysis of the cells dem-
onstrated that this prolonged stationary phase delayed apopto-
sis progression (Figure 2A) and increased the proportion of
cells within the G1 phase of the cell cycle from 46 to 64%,
which is consistent with previous studies (Figure 2B).5–8,10,12
The application of mild hypothermic conditions can increase
final product titer and is observed to do so here with an
increase at harvest point from 0.74 g L21 at 37C to 1.02 g
L21 at 32C. An increase in cell specific productivity, which
is also often associated with mild hypothermic culture condi-
tions,14 was not observed (Table 1). However, it did allow the
culture duration to be extended significantly and increase the
product titer on day of harvest. These findings were in agree-
ment with previous work performed in shake flasks, operated
in batch mode (data not shown). Increased cell specific
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productivity is known to be a cell line specific phenomenon;
however, it is interesting to note that cells cultured at 32C
showed a gradual increase in cell size during culture and that
when this is taken into account, the volume specific productiv-
ity at time of harvest approaches that observed in cells grown
at 37C. The effect of mild hypothermic conditions on product
quality was determined on days 12 and 20 for 32C and days
10 and 12 for 37C (Figure 3) by N-glycan analysis. It
showed that decreasing the culture temperature did not impact
on the glycosylation profile, whilst the length of culture had
an impact of the ratio of the glycosylated species, in agree-
ment with findings by Reid et al.28 As the culture progressed,
there was an increase in relative abundance of short glycans
(G0F) 48 to 52% and 53 to 58% for 32 and 37C, respec-
tively, and a decrease on the proportion of long glycans (G1F/
G2F) 41 to 36% for 32C and 38 to 35% for 37C.
Analysis of the HCP distribution
The HCP profile has been shown to be affected by physiologi-
cal differences prior to and during primary recovery24,29 and dif-
ferential expression of specific proteins in response to this state
may mean that the make-up of the impurity profile is changed.
For these reasons, the effect of mild hypothermic conditions on
the HCP content was investigated. The HCP content determined
by an industry standard ELISA assay30 was 50% higher in the
Figure 1. Growth profiles of mAb producing CHO cells
(GS-CY01) grown under standard and mild hypo-
thermic conditions (32C).
Cultures were grown in parallel STRs (3.5 L working volume)
with a temperature change from 37 to 32C implemented in
one bioreactor on day 6 of culture. The viable cell concentra-
tion ( 32C;  37C) and viability ( 32C; D 37C) were
determined. n5 3 (replicate cell counts)6 s.d. Product titer
was determined by protein G HPLC ( 32C; w 37C).
Figure 2. Effect of mild hypothermic (32C) culture conditions
on cell physiology.
Cultures were grown in parallel STRs (3.5 L working volume)
with a temperature change from 37 to 32C implemented in one
bioreactor on day 6 of culture. A: Apoptosis was determined by
flow cytometry for samples taken from the cultures at 32C [via-
ble (,—), early apoptotic (,—), and late apoptotic cells (,—
)] and 37C [viable (w,- -), early apoptotic (D,- -), and late apo-
ptotic cells (,- -)]. The trend lines represent second order linear
regressions. B: The cell cycle distribution was determined by
flow cytometry and the percentage in G1 (), S ( ), and G2/M
( ) subpopulations was calculated.
Figure 3. Glycosylation profiles of mAb producing CHO cells
(GS-CY01) grown under standard and mild hypo-
thermic conditions (32C).
Cultures were grown in parallel STRs (3.5 L working volume)
with a temperature change from 37 to 32C implemented in
one bioreactor on day 6 of culture. Samples removed on speci-
fied time points were purified by protein A chromatography
and the glycosylation profiles were determined, % relative area
of fucosylated and non-fucosylated glycans ( G0(F);
G1(F); G2(F). n5 3 (replicates of antibody sample)6 s.d.
Table 1. Specific Productivity, Volume Specific Productivity, and
Cell Size from CHO Cells (GS-CY01) Grown Under Mild Hypother-
mic and Standard Conditions
Time
(days)
Average Cell
Specific Pro-
ductivity (pg
cell21 d21)
Average Volume
Specific
Productivity
(pg mm23 d21)
Average
Cell Size
(mm)
32C 37C 32C 37C 32C 37C
0–6 7.1 12.6 1.23 3 104 2.10 3 104 15.0 14.9
7–13 6.5 12.7 1.57 3 104 3.03 3 104 16.1 16.5
14–20 7.7 N/A 2.68 3 104 N/A 18.3 N/A
Overall 7.2 11.8 1.92 3 104 2.78 3 104 16.5 15.7
N/A: Bioreactor was harvested on day 13.
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culture grown under mild hypothermic conditions, raising from
101,7416 13,211 ppm (ng per mg antibody) at 37C to
148,2646 13,610 ppm at 32C, measured on days 12 and 20,
respectively (Table 2). Under standard conditions the majority of
HCPs from the cell line used in this work have been shown to
be intracellularly located, arising from lysed or fragmented cells
during culture.24 The higher peak and harvest viable cell counts
and extended culture period associated with the culture grown
under mild hypothermic conditions are therefore likely to be sig-
nificant contributing factors accounting for this difference.
The differences in proportion of HCPs may be also due to
differential expression of these impurities as a result of imple-
menting hypothermic conditions during culture.31 As this
strategy has been adopted here and in light of differences in
abundance as determined by HCP ELISA two complementary
proteomic techniques, SELDI-TOF MS and 2D-PAGE, were
used to examine the individual components of this impurity
population (Figure 4). SELDI-TOF-MS has been used previ-
ously to examine HCP expression throughout culture24,32 and
HCPs during purification,26 but only now to examine differen-
ces as a result of physiological stress. 2D-PAGE is an exten-
sively used proteomic technique and can be coupled with
mass spectrometry for identification and has been used in a
number of studies to focussing on HCPs.22,24,29
For SELDI-TOF MS, chips with normal phase chemistry
were used to bind the majority of proteins present. An exam-
ple of the typical mass spectra output generated is shown in
Figure 4. Many of the prominent peaks are attributed to be
product related, or associated fragmented and multiply
charged species, however, in the lower mass range (<20 kDa)
many of the peaks are likely to be HCPs. Comparison of the
individual peaks observed within this range showed that the
majority of peaks had comparable areas, but there were a
small proportion of peaks having statistically significant dif-
ferences. Analysis by 2D-PAGE (Figure 4) provided further
evidence of minor differences in some individual HCPs,
although again the majority of spots had comparable volumes.
Although the proteomic methods used in this work suffer
from some limitations, as discussed in further detail in Tarrant
et al.,26 any differences in the impurity profile, even if minor,
may be significant as these are one of the primary impurities
targeted for removal during the purification process.33 This
also provides rationale for further examination of HCPs, when
changes to the existing production process are made, in partic-
ular on whether or not there is a consequence on the effec-
tiveness of the purification process. Improvements in sample
preparation (e.g., use of immunodepletion), implementation of
alternative proteomic techniques such as 2D LC-MS or exami-
nation of these impurities at the individual component level
(e.g., for HCPs which are shown to be product associating,
have protease activity or are associated with particular safety
concerns) would therefore greatly benefit efforts in future pro-
cess development and improve current process understanding.
Implications of mild hypothermic conditions on DSP
The benefits of high recombinant protein titer and product
quality associated with mild hypothermic conditions are well
established.9 It is also known (and demonstrated here) that the
implementation of such strategies and other changes in bio-
reactor conditions can have a dramatic effect on the physio-
logical state of the cells34,35 and that such changes can in turn
Figure 4. Representative example of a 2D-PAGE gel image (A)
and SELDI-TOF MS spectra (B), from the fed-batch
culture operated at 37C.
For 2D-PAGE, pH 3–10 nonlinear IPG strips and 4–12% Bis-
Tris SDS-PAGE gel were used, with a total protein load of 200
mg. All samples were run in triplicate and stained with Sypro
Ruby. For SELDI-TOF MS, analysis was performed using nor-
mal phase chips, with all samples run in triplicate. Peaks attrib-
uted to be product related species are indicated.
Table 2. HCP Analysis Under Standard and Mild Hypothermic
Conditions (32C)
32C 37C
HCP ELISA (mg HCP mg21 mAb) 1486 14 1026 13
HCP quantification was conducted using a commercially available
sandwich ELISA kit. The data shown is the average of triplicate replicates
within the range of the assay, normalized to the mAb concentration.
Figure 5. Effect of mild hypothermic growth conditions on the
response of CHO cells to shear.
Samples taken from fed-batch cultures operated at 32 or 37C
were exposed to shear environments that represent those typi-
cally experienced in industrial scale centrifuges. The viability
determined prior to and after application of the shear using a
Vi-Cell XR. The plots depicted here show the results from
samples that had the same pre-shear viability, represented here
as high [37C, day 10 (); 32C, day 12 ()] and low [37C,
day 12 (); 32C, day 20 (D)]. n5 3 (repeat viability
measurements)6 s.d.
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alter the way in which cells respond to shear forces. In addi-
tion, the shear experienced in DSP has also been well charac-
terized and shown to yield energy dissipation rates many
times higher than those typically seen in bioreactors,36 which
can have significant effects on the cell containing culture me-
dium.23,24,37 Here, we investigate the impact upstream process
conditions can have on the response of cells to the shear
forces experienced in DSP; specifically, disc-stack centrifuga-
tion, which is typically the first recovery stage in large-scale
mammalian cell culture. To enable a more comprehensive
study of different centrifugation conditions, we employed an
USD mimic of process scale centrifugation, which has been
previously used to evaluate this cell line.23,24
Cell culture material taken from bioreactors either con-
trolled at 32 or 37C were exposed to a range of shear con-
ditions that mimic those that would typically be experienced
during primary recovery using large-scale centrifugation. To
compare the performance from either culture the viability of
the cells pre-shear and post-shear was determined and the
clarification performance measured using an USD centrifuga-
tion mimic.23 Shear sensitivity of CHO cells has previously
been demonstrated to be associated with the viability of the
culture.23,24 However, the implementation of mild hypother-
mic conditions prolongs the period over which cells maintain
a high viability; therefore to ensure the response to DSP
observed is a fair comparison, cultures with the same viabil-
ity rather than those taken on the same day were compared,
that is, days 10 (91.6%) and 12 (81.2%) for 37C and 14
(91.9%) and 20 (83.2 %) for 32C cultures.
The reduction in culture viability with the implementation
of increasing energy can be considered a measure of the shear
sensitivity of the culture. When cultures taken from mild
hypothermic conditions and standard growth conditions are
compared (Figure 3), both cultures demonstrate an energy dis-
sipation threshold (0.195 3 106 W kg21) above which a
Figure 6. Effect of mild hypothermic culture conditions on centrif-
ugation performance predicted using an USD model.
Samples taken from fed-batch cultures operated at 32 or 37C were
exposed to shear environments that represent those typically experi-
enced in industrial scale centrifuges. The predicted clarification per-
formance was determined by centrifugation of sheared and non-
sheared samples in 96-well plates conditions to give V/c.t.R values
of 1.88 (,), 2.56 (,D) and 5.00 3 1028 m s21 (,w), 32C
(filled symbols), 37C (empty symbols).
Figure 7. Impact of temperature reduction on particle size distribution following mimic of centrifugal shear forces.
Samples were taken on day 6 (high viability) or 12 (low viability) and were immediately processed ( ) or adjusted to 4C ( ) and held for 5 h
prior to processing. Samples were sheared at 6,500 or 12,000 rpm, equivalent to maximum energy dissipation rates of 0.06 and 0.53 3 106 W kg21.
The particle sizes were determined using the CASY analyzer, with the data shown in each plot the relative frequency of an average of five repli-
cates. Viability, as determined using the Vi-Cell XR, is also indicated in each plot.
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significant reduction in viability is observed. However, cells
grown under mild hypothermic conditions show a smaller
reduction in viability indicating these cells are more shear re-
sistant. It has been suggested that the shear sensitivity of cells
relates to the stage of the cell cycle they are in, with those in
the G2 phase being larger and therefore more sensitive.35
However, we observed that when the viability of the culture
is taken into account, it is the culture conditions and not the
cell size being the predominant factor in shear sensitivity.
Cells that were harvested at a high viability were observed to
be the same average diameter (16.46 mm at 32C; 16.39 mm
at 37C) but showed a different reduction in viability (Figure
5). Those harvested at a low viability where the cells grown
at 32C were observed to be larger (19.71 mm at 32C; 17.52
mm at 37C) also showed a greater resistance to shear. Addi-
tion of cell culture components such as Pluronic F-68 have
been shown to increase membrane rigidity and as a result
reduce shear sensitivity.38 The cell membrane can also be
modified due to homeoviscous adaption to mild hypothermia,
in which the activation of specific cell signaling pathways
enables changes in the lipid composition to take place.39,40
The data presented therefore indicates that the implementation
of mild hypothermic conditions results in cells that are more
resistant to the hydrodynamic conditions experienced in DSP,
regardless of the difference in cell size observed.
Comparison of the centrifugation performance using a
multiwell plate based method demonstrates how the differ-
ence in shear sensitivity between the two cultures observed
in the cell viability data is translated into the solids remain-
ing observed after centrifugation (Figure 6). Where the cell
culture viability is high prior to centrifugation there is little
difference observed in the solids remaining where no shear
is applied, but on application of higher energy dissipation
rates (equivalent to those observed in nonhermetically sealed
centrifuge) a difference between the solids remaining in the
supernatant from the different cultures and all V/c.t.R values
measured was seen, rising to a difference of 4% under the
highest shear conditions and worst clarification conditions.
This poorer performance of the supernatant taken from the
37C was also observed from the cultures taken at a low via-
bility pre-shear, but is more pronounced.
To investigate further membrane fluidity properties on pri-
mary recovery performance, it was decided to perform
centrifugation analysis of material at harvest temperature (i.e.,
37C) and reduced to 4C for a shortened period considered
insufficient for homeoviscous adaption. Although temperature
reduction may not be appropriate for higher cell density cul-
tures for which centrifugation performance would be
adversely affected by viscosity effects, it was selected as both
a means to demonstrate the impact of membrane rigidity
because of temperature change and as a potential processing
strategy, which would be readily implementable. As shown in
Figures 7 and 8, temperature reduction has a dramatic effect
on particle size post shearing and the resulting clarification
levels achieved. Under high shear conditions, at both high and
low viability, the viable cell population was significantly
reduced when centrifugation was performed at standard har-
vest temperature, compared with reduced temperature. This is
particularly evident at high viability, when cells are more sus-
ceptible to shear under standard conditions.24 Reducing the
temperature of the cell culture material prior to centrifugation
protects this population, increasing the viable cell population
from 33.4 to 94.7% at high viability and under high shear
conditions, and results in improved clarification levels. Apo-
ptosis analysis of the sheared samples (data not shown) shows
that the early apoptotic and late apoptotic populations, both of
which are within the viable cell population are either com-
pletely lost or significantly reduced under any of the energy
dissipation rates investigated and either temperature. This indi-
cates that the apoptotic cells are therefore the most sensitive
sub-set of cells to shear.
The adaption of cells to temperature reduction, either
under long-term mild hypothermic conditions (i.e., homeo-
viscous adaption) as part of a cell culture strategy or as a
short term means to improve primary recovery performance
using a short-term pronounced temperature reduction has
been shown to beneficial to centrifugation performance. The
potential improvement associated with this change may ena-
ble centrifuge operation at a higher flow rate or a reduction
in the capacity of subsequent steps such as depth filtration to
achieve a similar level of clarification to the standard tem-
perature culture conditions.
Figure 8. Impact of temperature reduction of cell culture ma-
terial prior to centrifugation.
A: Samples were taken on days 6 (high viability) or 12 (low
viability) and adjusted to the specified temperature. Once the
target temperature was attained samples were sheared at 6,500
( for 37C, D for 4C) or 12,000 rpm ( for 37C,  for
4C), equivalent to maximum energy dissipation rates of 0.06
and 0.53 3 106 W kg21. The samples were then centrifuged in
conical bottom 96 deep round well plates at 3,000 rpm for 5 or
10 min, with different fill volumes to achieve V/c.t.R values of
between 1.67 and 5.69 3 1028 m s21, equivalent to volumetric
flow rates of 39 to 134 L h21. B: Apoptosis was determined by
flow cytometry. The viable (W), early apoptotic ( ), late apo-
ptotic ( ), and nonviable cells populations (w) of the samples
were determined on day 12.
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Conclusions
Implementation of mild hypothermic conditions during
culture prolonged the stationary phase, delayed the progres-
sion into apoptosis, and maintained higher viability. These
effects were associated with increases in volumetric produc-
tivity. The glycosylation profile of the mAb used in this
work was affected by culture time, but not significantly by
the temperature conditions selected. Despite the increase in
product titer on day of harvest when adopting a process
using mild hypothermic conditions, the potential impact of
implementing such changes further downstream is a signifi-
cant consideration at process scale. Evaluation of HCP
impurities by ELISA, SELDI-TOF MS and 2D-PAGE indi-
cated that there were differences in impurity profiles, which
may affect purification performance. Cellular adaption to
growth at reduced temperature or short-term reduction imme-
diately prior to primary recovery lowered the susceptibility
of the cells to shear stress and we demonstrated that this
affected process scale centrifugation, improving primary re-
covery performance.
In this work, by applying of a number of process and ana-
lytical characterization methods, we have demonstrated the
close relationship between upstream and downstream opera-
tions and the value of improving their integration during pro-
cess development. The knowledge gained from evaluations
similar to those performed here may therefore be supplemen-
tary to the cost of goods analyses, which typically help to
determine the value of novel cell culture strategies in bio-
pharmaceutical manufacture and provide further support
when deciding on their implementation.
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